查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594655

眼藥水市場：按類型、類別、最終用戶、適應症分類 - 全球預測 2025-2030

Ophthalmic Drops Market by Type (Over-the-counter Eye Drops, Prescription Eye Drops), Category (Anesthetic Drops, Antibiotic Drops, Dilation Drops), End User, Indications - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年眼藥水市場規模為12.2億美元，預計2024年將達到13.1億美元，複合年成長率為7.11%，2030年將達到19.8億美元。

眼藥水市場專注於治療各種眼部疾病的產品，如乾燥、過敏、感染疾病和青光眼。市場範圍從非處方藥到處方藥，應用廣泛，包括潤滑、感染疾病控制、過敏緩解和眼壓調節等。這種多樣化的應用程式滿足了個人最終用戶的需求，例如患有慢性病的患者或尋求即時緩解的患者，以及機構相關人員，例如醫院和診所。主要成長動力包括人口老化導致與老齡化相關的眼部疾病發病率增加、數位螢幕的廣泛使用導致數位眼睛疲勞以及藥物輸送系統的技術進步。最近的進展，特別是不含防腐劑的配方和新的藥物傳遞機制，引起了人們的極大興趣。醫療基礎設施發達、眼健康意識不斷增強的新興國家市場拓展存在潛在商機。此外，遠端醫療和線上藥局為分發和教育提供了不斷發展的平台，特別是在偏遠地區。然而，嚴格的監管標準、長期使用的潛在副作用以及價格敏感的學名藥的競爭等挑戰正在阻礙市場成長。創新機會包括開發同時解決多種症狀的多活性製劑、透過易於使用的輸送系統來提高患者的依從性，以及人工智慧驅動的個人化治療方法。投資生物有效性和緩釋性的研究可以提供競爭優勢。眼藥水市場具有彈性並有望成長，平衡創新與監管和定價挑戰。在技​​術進步、對消費者安全的關注以及對整個醫療保健領域預防保健的日益關注的推動下，市場持續充滿活力。解決這些因素對於有效利用市場機會至關重要。

主要市場統計
基準年[2023] 12.2億美元
預測年份 [2024] 13.1億美元
預測年份 [2030] 19.8億美元
複合年成長率（%） 7.11%

市場動態：揭示快速發展的眼藥水市場的關鍵市場洞察

供需的動態交互作用正在改變眼藥水市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 人群中眼科疾病和眼部感染疾病的盛行率上升
    • 世界人口老化不斷加劇，隨之而來的眼科手術數量也增加。
    • 由於螢幕時間增加，兒童和青少年的視力問題增加
  • 市場限制因素
    • 眼藥水的全身副作用
  • 市場機會
    • 眼藥水的新研發方法
    • 加大眼科藥品投入
  • 市場挑戰
    • 患者報告的眼藥水問題和產品召回

波特五力：駕馭眼藥水市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解眼藥水市場的外部影響

外部宏觀環境因素對眼藥水市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解眼藥水市場競爭狀況

對眼藥水市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣眼藥水市場供應商績效評估

FPNV定位矩陣是評估眼藥水市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，描繪眼藥水市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對眼藥水市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人群中眼部疾病和眼部感染疾病的盛行率增加
      • 全球人口老化不斷加劇，眼科手術數量也隨之增加。
      • 由於螢幕時間增加，兒童和青少年的視力問題增加
    • 抑制因素
      • 眼藥水的全身副作用
    • 機會
      • 眼藥水的新研發方法
      • 加大眼科藥品投入
    • 任務
      • 患者報告的眼藥水問題和產品召回
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 眼藥水市場：依類型

  • 非處方眼藥水
  • 處方眼藥水

第7章 眼藥水市場：依類別

  • 麻醉眼藥水
  • 抗生素眼藥水
  • 腫脹眼藥水
  • 青光眼眼藥水
  • 類固醇滴注

第8章 眼藥水市場：依最終用戶分類

  • 眼科診所
  • 醫院
  • 醫療機構
  • 調查機構

第9章依適應症分類的眼藥水市場

  • 老齡化黃斑部病變
  • 白內障
  • 青光眼
  • 發炎疾病
  • 屈光不正

第10章 北美、南美眼藥水市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太眼藥水市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的眼藥水市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • Akorn, Inc.
  • Alcon Inc.
  • Amneal Pharmaceuticals, Inc.
  • Apotex Inc.
  • Bausch & Lomb Incorporated
  • Catalent, Inc.
  • CVS Health
  • Duopharma Biotech Berhad
  • Geri-Care Pharmaceuticals Corp.
  • Honeywell International Inc.
  • ImprimisRx
  • Johnson & Johnson Services, Inc.
  • KC Pharmaceuticals, Inc.
  • Mankind Pharma Ltd.
  • Mylan NV
  • Novartis AG
  • OCuSOFT, Inc.
  • Orimed Pharma Inc.
  • Pfizer, Inc.
  • Preferred Pharmaceuticals Inc.
  • Prestige Consumer Healthcare Inc.
  • ROHTO Pharmaceutical Co., Ltd.
  • Sager Pharma Kft.
  • Santen Pharmaceutical Co., Ltd.
  • Similasan Corporation
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Wockhardt
Product Code: MRR-814AB2699980

The Ophthalmic Drops Market was valued at USD 1.22 billion in 2023, expected to reach USD 1.31 billion in 2024, and is projected to grow at a CAGR of 7.11%, to USD 1.98 billion by 2030.

The ophthalmic drops market focuses on products designed for treating a variety of eye conditions such as dryness, allergies, infections, and glaucoma. The market's scope extends from over-the-counter formulations to prescription medications and spans diverse applications including lubrication, infection control, allergy relief, and intraocular pressure regulation. This diversity in application caters to individual end-users, such as patients with chronic conditions or those seeking immediate relief, and institutional stakeholders like hospitals and clinics. Key growth drivers include an aging population leading to an increased incidence of age-related eye disorders, widespread digital screen usage leading to digital eye strain, and technological advancements in drug delivery systems. Recent advancements, particularly in preservative-free formulations and novel drug delivery mechanisms, are generating considerable interest. Potential opportunities lie in expanding the market in emerging economies with growing healthcare infrastructure and increased awareness about ocular health. Furthermore, telemedicine and online pharmacies present a growing platform for distribution and education, especially in remote regions. However, market growth is hindered by challenges such as stringent regulatory standards, potential side effects associated with long-term use, and significant competition from generic products that drive price sensitivity. Innovation opportunities include developing multi-action formulations that address several symptoms at once, improving patient compliance through user-friendly delivery systems, and leveraging AI for personalized treatment regimens. Investment in research focused on bioavailability and extended-release formulations could offer competitive advantages. The ophthalmic drops market is resilient and poised for growth, balancing innovation with regulatory and pricing challenges. It remains dynamic, driven by technological advancements, an emphasis on consumer safety, and an increasing inclination toward preventive care within the healthcare continuum. Addressing these factors will be central to leveraging market opportunities effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 1.22 billion
Estimated Year [2024] USD 1.31 billion
Forecast Year [2030] USD 1.98 billion
CAGR (%) 7.11%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Ophthalmic Drops Market

The Ophthalmic Drops Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising Prevalence of Ophthalmic Disease and Eye Infection among the Population
    • Growing Old Age Population and Associated Eye-Surgeries Worldwide
    • Growth of Vision Problems in Kids and Younger Population due to More Screen Time
  • Market Restraints
    • Systemic Side Effects of Ophthalmic Drops
  • Market Opportunities
    • New Research & Development Approach to Ophthalmic Drops
    • Increase in Investment for Ophthalmology Medication
  • Market Challenges
    • Patient-Reported Problems Related to Eye Drop Instillation and Product Recall

Porter's Five Forces: A Strategic Tool for Navigating the Ophthalmic Drops Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Ophthalmic Drops Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Ophthalmic Drops Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Ophthalmic Drops Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Ophthalmic Drops Market

A detailed market share analysis in the Ophthalmic Drops Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Ophthalmic Drops Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Ophthalmic Drops Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Ophthalmic Drops Market

A strategic analysis of the Ophthalmic Drops Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Ophthalmic Drops Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Akorn, Inc., Alcon Inc., Amneal Pharmaceuticals, Inc., Apotex Inc., Bausch & Lomb Incorporated, Catalent, Inc., CVS Health, Duopharma Biotech Berhad, Geri-Care Pharmaceuticals Corp., Honeywell International Inc., ImprimisRx, Johnson & Johnson Services, Inc., KC Pharmaceuticals, Inc., Mankind Pharma Ltd., Mylan N.V., Novartis AG, OCuSOFT, Inc., Orimed Pharma Inc., Pfizer, Inc., Preferred Pharmaceuticals Inc., Prestige Consumer Healthcare Inc., ROHTO Pharmaceutical Co., Ltd., Sager Pharma Kft., Santen Pharmaceutical Co., Ltd., Similasan Corporation, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Wockhardt.

Market Segmentation & Coverage

This research report categorizes the Ophthalmic Drops Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Over-the-counter Eye Drops and Prescription Eye Drops.
  • Based on Category, market is studied across Anesthetic Drops, Antibiotic Drops, Dilation Drops, Glaucoma Drops, and Steroid Drops.
  • Based on End User, market is studied across Eye Clinic, Hospitals, Medical Institutes, and Research Organizations.
  • Based on Indications, market is studied across Age-Related Macular Degeneration, Cataract, Glaucoma, Inflammatory Diseases, and Refractive Disorders.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Prevalence of Ophthalmic Disease and Eye Infection among the Population
      • 5.1.1.2. Growing Old Age Population and Associated Eye-Surgeries Worldwide
      • 5.1.1.3. Growth of Vision Problems in Kids and Younger Population due to More Screen Time
    • 5.1.2. Restraints
      • 5.1.2.1. Systemic Side Effects of Ophthalmic Drops
    • 5.1.3. Opportunities
      • 5.1.3.1. New Research & Development Approach to Ophthalmic Drops
      • 5.1.3.2. Increase in Investment for Ophthalmology Medication
    • 5.1.4. Challenges
      • 5.1.4.1. Patient-Reported Problems Related to Eye Drop Instillation and Product Recall
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Ophthalmic Drops Market, by Type

  • 6.1. Introduction
  • 6.2. Over-the-counter Eye Drops
  • 6.3. Prescription Eye Drops

7. Ophthalmic Drops Market, by Category

  • 7.1. Introduction
  • 7.2. Anesthetic Drops
  • 7.3. Antibiotic Drops
  • 7.4. Dilation Drops
  • 7.5. Glaucoma Drops
  • 7.6. Steroid Drops

8. Ophthalmic Drops Market, by End User

  • 8.1. Introduction
  • 8.2. Eye Clinic
  • 8.3. Hospitals
  • 8.4. Medical Institutes
  • 8.5. Research Organizations

9. Ophthalmic Drops Market, by Indications

  • 9.1. Introduction
  • 9.2. Age-Related Macular Degeneration
  • 9.3. Cataract
  • 9.4. Glaucoma
  • 9.5. Inflammatory Diseases
  • 9.6. Refractive Disorders

10. Americas Ophthalmic Drops Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Ophthalmic Drops Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Ophthalmic Drops Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Akorn, Inc.
  • 3. Alcon Inc.
  • 4. Amneal Pharmaceuticals, Inc.
  • 5. Apotex Inc.
  • 6. Bausch & Lomb Incorporated
  • 7. Catalent, Inc.
  • 8. CVS Health
  • 9. Duopharma Biotech Berhad
  • 10. Geri-Care Pharmaceuticals Corp.
  • 11. Honeywell International Inc.
  • 12. ImprimisRx
  • 13. Johnson & Johnson Services, Inc.
  • 14. KC Pharmaceuticals, Inc.
  • 15. Mankind Pharma Ltd.
  • 16. Mylan N.V.
  • 17. Novartis AG
  • 18. OCuSOFT, Inc.
  • 19. Orimed Pharma Inc.
  • 20. Pfizer, Inc.
  • 21. Preferred Pharmaceuticals Inc.
  • 22. Prestige Consumer Healthcare Inc.
  • 23. ROHTO Pharmaceutical Co., Ltd.
  • 24. Sager Pharma Kft.
  • 25. Santen Pharmaceutical Co., Ltd.
  • 26. Similasan Corporation
  • 27. Sun Pharmaceutical Industries Ltd.
  • 28. Teva Pharmaceutical Industries Ltd.
  • 29. Wockhardt

LIST OF FIGURES

  • FIGURE 1. OPHTHALMIC DROPS MARKET RESEARCH PROCESS
  • FIGURE 2. OPHTHALMIC DROPS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL OPHTHALMIC DROPS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES OPHTHALMIC DROPS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES OPHTHALMIC DROPS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. OPHTHALMIC DROPS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. OPHTHALMIC DROPS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. OPHTHALMIC DROPS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL OPHTHALMIC DROPS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. OPHTHALMIC DROPS MARKET DYNAMICS
  • TABLE 7. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY OVER-THE-COUNTER EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY PRESCRIPTION EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY ANESTHETIC DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY ANTIBIOTIC DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY DILATION DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY GLAUCOMA DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY STEROID DROPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY EYE CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY MEDICAL INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY CATARACT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY GLAUCOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL OPHTHALMIC DROPS MARKET SIZE, BY REFRACTIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES OPHTHALMIC DROPS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DROPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM OPHTHALMIC DROPS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM OPHTHALMIC DROPS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM OPHTHALMIC DROPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM OPHTHALMIC DROPS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 195. OPHTHALMIC DROPS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 196. OPHTHALMIC DROPS MARKET, FPNV POSITIONING MATRIX, 2023